Is it time to repurpose geroprotective diabetes medications for prevention of dementia?

J Am Geriatr Soc. 2023 Jul;71(7):2041-2045. doi: 10.1111/jgs.18405. Epub 2023 May 25.

Authors

Diana He¹, Sandra Aleksic²

Affiliations

¹ Department of Internal Medicine, Montefiore Medical Center, Bronx, New York, USA.
² Department of Internal Medicine, Divisions of Endocrinology and Geriatrics, Albert Einstein College of Medicine, Bronx, New York, USA.

PMID: 37227136
PMCID: PMC10524156 (available on 2024-07-01)
DOI: 10.1111/jgs.18405

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Comment

MeSH terms

Dementia* / drug therapy
Dementia* / prevention & control
Diabetes Mellitus, Type 2* / drug therapy
Humans
Hypoglycemic Agents / therapeutic use

Substances

Hypoglycemic Agents

Grants and funding